Kyoko Haraguchi

Tokyo Metropolitan Komagome Hospital

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Tokyo Metropolitan Komagome Hospital

Research Subjects

Research Interests

Kyoko Haraguchi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

Noriko Doki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan
4 shared publications
Atsushi Jinguji
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
3 shared publications
Hiroaki Shimizu
3 shared publications
Masashi Shimabukuro
3 shared publications
Naoki Shingai
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
3 shared publications
Yuho Najima
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
3 shared publications

Latest Publications

Sort by

Website
Google Scholar
- 6 November 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Infusion timing and outcomes after allogeneic hematopoietic cell transplantation across graft sources
by Shuhei Kurosawa, Tomomi Toubai, Atsushi Jinguji, Naoki Shingai, Takashi Toya, Kaoru Morita, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Kyoko Haraguchi, et al.
Website
Google Scholar
- 6 November 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Infusion timing and outcomes after allogeneic hematopoietic cell transplantation across graft sources
by Shuhei Kurosawa, Tomomi Toubai, Atsushi Jinguji, Naoki Shingai, Takashi Toya, Kaoru Morita, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Kyoko Haraguchi, et al.
Website
Google Scholar
- 29 August 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Peripheral Neuropathy After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Electrophysiologic Features
by Shuhei Kurosawa, Yukie Ishizaka, Kozue Tanaka, Ryohei Nagata, Shuntaro Ikegawa, Kenji Ishibashi, Masayuki Baba, Masashi Shimabukuro, Atsushi Jinguji, Naoki Shingai, et al.
Website
Google Scholar
- 29 August 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Peripheral Neuropathy After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Electrophysiologic Features
by Shuhei Kurosawa, Yukie Ishizaka, Kozue Tanaka, Ryohei Nagata, Shuntaro Ikegawa, Kenji Ishibashi, Masayuki Baba, Masashi Shimabukuro, Atsushi Jinguji, Naoki Shingai, et al.
Website
Google Scholar
- 30 March 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation
by Ryo Hasunuma, Hiroaki Shimizu, Daichi Sadato, Chizuko Hirama, Masashi Shimabukuro, Atsushi Jinguji, Kaoru Morita, Takashi Toya, Yuho Najima, Tomomi Toubai, et al.
Website
Google Scholar
- 30 March 2026
- Published by Elsevier in Transplantation and Cellular Therapy
Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation
by Ryo Hasunuma, Hiroaki Shimizu, Daichi Sadato, Chizuko Hirama, Masashi Shimabukuro, Atsushi Jinguji, Kaoru Morita, Takashi Toya, Yuho Najima, Tomomi Toubai, et al.
Website
Google Scholar
Cited by 3
- 16 March 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era
by Atsushi Jinguji, Shuhei Kurosawa, Takashi Toya, Kana Kato, Yasutaka Sadaga, Kaori Kondo, Fumihiko Ouchi, Masashi Shimabukuro, Naoki Shingai, Hiroaki Shimizu, et al.
Website
Google Scholar
- 16 March 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era
by Atsushi Jinguji, Shuhei Kurosawa, Takashi Toya, Kana Kato, Yasutaka Sadaga, Kaori Kondo, Fumihiko Ouchi, Masashi Shimabukuro, Naoki Shingai, Hiroaki Shimizu, et al.
Cited by 3